Equine infectious anaemia virus (EIAV) is the aetiological agent of equine infectious anaemia (EIA), a notifiable disease within the EU and to the OIE. In Great Britain, EIA cases were reported in 1975--1978; then followed a disease-free period until 2010--2012, when six positive animals were identified. As a member of the family Retroviridae and genus *Lentivirus*, EIAV shares the lentiviral trait of considerable genetic variation which has hampered development of molecular diagnostics. In addition, there is a lack of publically available sequence data, hence our intention was to conduct molecular characterisation of the British cases. A combination of Sanger and next-generation sequencing (NGS) was employed in order to determine viral sequences. Using Sanger sequencing only small genomic fragments could be recovered, hence efforts were refocused on NGS. Phylogenetic analysis and evaluation of sequence diversity of the British sequences were assessed using the MEGA5 software. Full-genome sequences were obtained from symptomatic cases in 1975, 2010, and 2012. Phylogenetic analysis of these sequences revealed that each British case formed its own branch on the tree as did sequences from America, China, Ireland, and Japan. Almost an equal distance was observed between each of the isolates, with nucleotide homology of 75--79 per cent. Nucleic acid identity of the full-genome sequences varied between individual genes and ranged from 46 per cent (P9) to 98 per cent (protease). EIAV's variable nature made the use of primer walking sequencing strategies laborious, whereas attaining full genome via NGS was relatively straightforward. However, it is not without its problems as significant viral load is required to overcome the high host background typical of clinical extractions rendering sequencing of asymptomatic cases problematic. As the British asymptomatic cases provided limited or no sequence, investigation is ongoing into strategies to elucidate these sequences. Currently EIAV diagnosis relies solely on serological testing; increased genetic information from diverse sources should enable PCR design that will reliably detect a wide range of strains thus facilitating diagnosis and epidemiological analysis of outbreaks.
